» Articles » PMID: 27225672

Solution Structure and Binding Specificity of the P63 DNA Binding Domain

Overview
Journal Sci Rep
Specialty Science
Date 2016 May 27
PMID 27225672
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

p63 is a close homologue of p53 and, together with p73, is grouped into the p53 family of transcription factors. p63 is known to be involved in the induction of controlled apoptosis important for differentiation processes, germ line integrity and development. Despite its high homology to p53, especially within the DNA binding domain (DBD), p63-DBD does not show cooperative DNA binding properties and is significantly more stable against thermal and chemical denaturation. Here, we determined the solution structure of p63-DBD and show that it is markedly less dynamic than p53-DBD. In addition, we also investigate the effect of a double salt bridge present in p53-DBD, but not in p63-DBD on the cooperative binding behavior and specificity to various DNA sites. Restoration of the salt bridges in p63-DBD by mutagenesis leads to enhanced binding affinity to p53-specific, but not p63-specific response elements. Furthermore, we show that p63-DBD is capable of binding to anti-apoptotic BclxL via its DNA binding interface, a feature that has only been shown for p53 so far. These data suggest that all p53 family members - despite alterations in the specificity and binding affinity - are capable of activating pro-apoptotic pathways in a tissue specific manner.

Citing Articles

Disease-related p63 DBD mutations impair DNA binding by distinct mechanisms and varying degree.

Osterburg C, Ferniani M, Antonini D, Frombach A, DAuria L, Osterburg S Cell Death Dis. 2023; 14(4):274.

PMID: 37072394 PMC: 10113246. DOI: 10.1038/s41419-023-05796-y.


The paradoxical roles of miR-4295 in human cancer: Implications in pathogenesis and personalized medicine.

Li Y, Zhang Y, Zou Y, Duan S Genes Dis. 2022; 9(3):638-647.

PMID: 35782974 PMC: 9243315. DOI: 10.1016/j.gendis.2020.09.007.


Delineating functional mechanisms of the p53/p63/p73 family of transcription factors through identification of protein-protein interactions using interface mimicry.

Guven-Maiorov E, Sakakibara N, Ponnamperuma R, Dong K, Matar H, King K Mol Carcinog. 2022; 61(7):629-642.

PMID: 35560453 PMC: 9949960. DOI: 10.1002/mc.23405.


Structural diversity of p63 and p73 isoforms.

Osterburg C, Dotsch V Cell Death Differ. 2022; 29(5):921-937.

PMID: 35314772 PMC: 9091270. DOI: 10.1038/s41418-022-00975-4.


Evolutionary history of the p53 family DNA-binding domain: insights from an Alvinella pompejana homolog.

Zhang Q, Balourdas D, Baron B, Senitzki A, Haran T, Wiman K Cell Death Dis. 2022; 13(3):214.

PMID: 35256607 PMC: 8901663. DOI: 10.1038/s41419-022-04653-8.


References
1.
Schlereth K, Beinoraviciute-Kellner R, Zeitlinger M, Bretz A, Sauer M, Charles J . DNA binding cooperativity of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell. 2010; 38(3):356-68. DOI: 10.1016/j.molcel.2010.02.037. View

2.
Tomita Y, Marchenko N, Erster S, Nemajerova A, Dehner A, Klein C . WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J Biol Chem. 2006; 281(13):8600-6. DOI: 10.1074/jbc.M507611200. View

3.
Cornilescu G, Delaglio F, Bax A . Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR. 1999; 13(3):289-302. DOI: 10.1023/a:1008392405740. View

4.
Duijf P, Vanmolkot K, Propping P, Friedl W, Krieger E, McKeon F . Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63. Hum Mol Genet. 2002; 11(7):799-804. DOI: 10.1093/hmg/11.7.799. View

5.
Ianakiev P, Kilpatrick M, Toudjarska I, Basel D, Beighton P, Tsipouras P . Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27. Am J Hum Genet. 2000; 67(1):59-66. PMC: 1287102. DOI: 10.1086/302972. View